|
1
|
Cuisset T, Deharo P, Quilici J, Johnson
TW, Deffarges S, Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert
M, et al: Benefit of switching dual antiplatelet therapy after
acute coronary syndrome: The TOPIC (timing of platelet inhibition
after acute coronary syndrome) randomized study. Eur Heart J.
38:3070–3078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kai ME and Lindahl B: Application of
cardiac troponin in cardiovascular diseases other than acute
coronary syndrome. Clin Chem. 63:223–235. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hamm CW, Bertrand M and Braunwald E: Acute
coronary syndrome without ST elevation: Implementation of the new
guidelines. Lancet. 358:1533–1538. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Katus H, Ziegler A, Ekinci O, Giannitsis
E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson
P, Comaniciu D, et al: Early diagnosis of acute coronary syndrome.
Eur Heart J. 38:3049–3055. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mishra B, Pandey S, Niraula SR, Rai BK,
Karki P, Baral N and Lamsal M: Utility of ischemia modified albumin
as an early marker for diagnosis of acute coronary syndrome. J
Nepal Health Res Counc. 16:16–21. 2018.PubMed/NCBI
|
|
6
|
Peterson JM, Wei Z, Seldin MM, Byerly MS,
Aja S and Wong GW: CTRP9 transgenic mice are protected from
diet-induced obesity and metabolic dysfunction. Am J Physiol Regul
Integr Comp Physiol. 305:R522–R533. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li J, Zhang P, Li T, Liu Y, Zhu Q, Chen T,
Liu T, Huang C, Zhang J, Zhang Y and Guo Y: CTRP9 enhances carotid
plaque stability by reducing pro-inflammatory cytokines in
macrophages. Biochem Biophys Res Commun. 458:890–895.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu T, Guo Y, Li T, Zhang J, Li J and
Zhang P: Association of serum CTRP9 and APN levels with acute
coronary syndrome. J Shandong Univ. 52:58–62. 2014.
|
|
9
|
Gao C, Zhao S, Lian K, Mi B, Si R, Tan Z,
Fu F, Wang S, Wang R, Ma X and Tao L: C1q/TNF-related protein 3
(CTRP3) and 9 (CTRP9) concentrations are decreased in patients with
heart failure and are associated with increased morbidity and
mortality. BMC Cardiovasc Disord. 19(139)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
George M, Shanmugam E, Srivatsan V,
Vasanth K, Ramraj B, Rajaram M, Jena A, Sridhar A, Chaudhury M and
Kaliappan I: Value of pentraxin-3 and galectin-3 in acute coronary
syndrome: A short-term prospective cohort study. Ther Adv
Cardiovasc Dis. 9(275)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Barazzoni R, Aleksova A, Carriere C,
Cattin MR, Zanetti M, Vinci P, Stolfo D, Guarnieri G and Sinagra G:
Obesity and high waist circumference are associated with low
circulating pentraxin-3 in acute coronary syndrome. Cardiovasc
Diabetol. 12:167. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Anderson JL, Adams CD, Antman EM, Bridges
CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS,
Levin TN, et al: 2012 ACCF/AHA focused update incorporated into the
ACCF/AHA 2007 guidelines for the management of patients with
unstable angina/non-ST-elevation myocardial infarction: A report of
the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines. J Am Coll Cardiol.
61:e179–e347. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mehrshad V: State-of-the-art diagnosis of
myocardial infarction. Diagnosis (Berl). 3:137–142. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Panovský R, Borová J, Pleva M, Feitová V,
Novotný P, Kincl V, Holeček T, Meluzín J, Sochor O and Štěpánová R:
The unique value of cardiovascular magnetic resonance in patients
with suspected acute coronary syndrome and culprit-free coronary
angiograms. BMC Cardiovasc Disord. 17(170)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chacko S, Haseeb S, Glover BM, Wallbridge
D and Harper A: The role of biomarkers in the diagnosis and risk
stratification of acute coronary syndrome. Future Sci Oa.
4(FSO251)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang W, Ren D, Wang CS and Yao HC:
Nardilysin: A potential biomarker for the early diagnosis of acute
coronary syndrome. Int J Cardiol. 265(39)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Choi KM, Hwang SY, Hong HC, Choi HY, Yoo
HJ, Youn BS, Baik SH and Seo HS: Implications of C1q/TNF-related
protein-3 (CTRP-3) and progranulin in patients with acute coronary
syndrome and stable angina pectoris. Cardiovasc Diabetol.
13(14)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gustin C, Delaive E, Dieu M, Calay D and
Raes M: Up-regulation of pentraxin-3 in human endothelial cells
after lysophosphatidic acid exposure. Arterioscler Thromb Vasc
Biol. 28:491–497. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kotooka N, Inoue T, Aoki S, Anan M, Komoda
H and Node K: Prognostic value of pentraxin 3 in patients with
chronic heart failure. Int J Cardiol. 130:19–22. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hasic S, Kadic D, Kiseljakovic E, Jadric R
and Spahic E: Serum uric acid could differentiate acute myocardial
infarction and unstable angina pectoris in hyperuricemic acute
coronary syndrome patients. Med Arch. 71:115–118. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Natsukawa T, Maeda N, Fukuda S, Yamaoka M,
Fujishima Y, Nagao H, Sato F, Nishizawa H, Sawano H, Hayashi Y, et
al: Significant association of serum adiponectin and creatine
kinase-MB levels in ST-segment elevation myocardial infarction. J
Atheroscler Thromb. 24:793–803. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hong YJ, Jeong MH, Choi YH, Cho SH, Hwang
SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, et al: Relation
between high-sensitivity C-reactive protein and coronary plaque
components in patients with acute coronary syndrome: Virtual
histology-intravascular ultrasound analysis. Korean Circ J.
41:440–446. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cheng GD: RDW value for assessment of the
severity of acute coronary syndrome and its correlation with serum
indexes. J Hainan Med Univ, 2016.
|
|
24
|
Kambara T, Ohashi K, Shibata R, Ogura Y,
Maruyama S, Enomoto T, Uemura Y, Shimizu Y, Yuasa D, Matsuo K, et
al: CTRP9protein protects against myocardial injury following
ischemia-reperfusion through AMP-activated protein kinase
(AMPK)-dependent mechanism. J Biol Chem. 287:18965–18973.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Uemura Y, Shibata R, Ohashi K, Enomoto T,
Kambara T, Yamamoto T, Ogura Y, Yuasa D, Joki Y, Matsuo K, et al:
Adipose-derived factor CTRP9atenuates vascular smooth muscle cell
proliferation and neointimal formation. FASEB J. 27:25–33.
2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kambara T, Shibata R, Ohashi K, Matsuo K,
Hiramatsu-Ito M, Enomoto T, Yuasa D, Ito M, Hayakawa S, Ogawa H, et
al: C1q/tumor necrosis factor-related protein 9 protects against
acute myocardial injury through an adiponectin receptor
I-AMPK-dependent mechanism. Mol Cel Biol. 35:2173–2185.
2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Niemann B, Li L, Siegler D, Siegler BH,
Knapp F, Hanna J, Aslam M, Kracht M, Schulz R and Rohrbach S: CTRP9
mediates protective effects in cardiomyocytes via AMPK- and
adiponectin receptor-mediated induction of anti-oxidant response.
Cells. 9(1229)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Eggers KM, Armstrong PW, Califf RM,
Johnston N, Simoons ML, Venge P and James S: Clinical and
prognostic implications of circulating pentraxin 3 levels in non
ST-elevation acute coronary syndrome. Clin Biochem. 46:1655–1659.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Inoue K, Sugiyama A, Reid PC, Ito Y,
Miyauchi K, Mukai S, Safara M, Miyamoto K, Satoh H, Kohno I, et al:
Establishmen of a high sensitivity plasma assay for human pentraxin
3 as a marker for unstable angina pectoris. Arterioscler Thromb
Vasc Biol. 27:161–167. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Khamitova AF, Lakman IA, Akhmetvaleev RR,
Tulbaev EL, Gareeva DF, Zagidullin SZ and Zagidullin NS:
Multifactor predictive model in patients with myocardial infarction
based on modern biomarkers. Kardiologiia. 60:14–20. 2020.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
